Gd3+-DTPA-DG: novel nanosized dual anticancer and molecular imaging agent

Abstract

Difficulties in the use, preparation, and cost of radioactively-labeled glycosylated compounds led to this research and development study of a new gadolinium-labeled glucose compound that does not have a radioactive half-life or difficulties in its synthesis and utilization.